Abstract
Background: Nanoparticles (NPs) are a group of particles with at least one dimension ranging from 1 nm to 100 nm in diameter and a surrounding interfacial layer. The NP-protein interactions include covalent and non-covalent bonds. Several dehydrogenase enzymes (e.g., alcohol dehydrogenase, lactate dehydrogenase, alanine dehydrogenase, glutamate dehydrogenase, leucine dehydrogenase, phenylalanine dehydrogenase, and malate dehydrogenase) are used for immobilization by NPs. Also, magnetic NPs and quantum dots are promising model systems for the design of bioanalytical sensors and biological enzyme assemblies. In this overview, we aimed to improve the current knowledge of interactions between dehydrogenase enzymes and NPs and to introduce dehydrogenases with industrial and medical applications. Also, bioconjugation of NPs with dehydrogenase enzymes has broad applications in biocatalysis and nanomedicine in the field of drug discovery. However, studies on the characterization of NP-enzyme complexes show that the anatomy and activity of enzymes are dependent on the chemistry of NP ligands, NP size, and labeling methods. Moreover, the NPprotein conjugates show increased/decreased enzymatic activities, depending on the NP features.
Conclusion: In this study, we reviewed the findings related to NP-enzyme interactions for nanotechnology applications and conjugation techniques. We also highlighted several challenges associated with the NP-enzyme interactions, including the stability and reusability of enzymes in NP-enzyme formation.
Keywords: Dehydrogenase enzymes, Protein-ligand interaction, Immobilization, Magnetic nanoparticles, Quantum dots, Nanotechnology, Biosensors.
Mini-Reviews in Medicinal Chemistry
Title:Interaction of Dehydrogenase Enzymes with Nanoparticles in Industrial and Medical Applications, and the Associated Challenges: A Mini-review
Volume: 21 Issue: 11
Author(s): Samaneh J. Porzani, Adriana S. Lorenzi, Masoumeh Eghtedari and Bahareh Nowruzi*
Affiliation:
- Department of Biology, Science and Research Branch, Islamic Azad University, Tehran,Iran
Keywords: Dehydrogenase enzymes, Protein-ligand interaction, Immobilization, Magnetic nanoparticles, Quantum dots, Nanotechnology, Biosensors.
Abstract:
Background: Nanoparticles (NPs) are a group of particles with at least one dimension ranging from 1 nm to 100 nm in diameter and a surrounding interfacial layer. The NP-protein interactions include covalent and non-covalent bonds. Several dehydrogenase enzymes (e.g., alcohol dehydrogenase, lactate dehydrogenase, alanine dehydrogenase, glutamate dehydrogenase, leucine dehydrogenase, phenylalanine dehydrogenase, and malate dehydrogenase) are used for immobilization by NPs. Also, magnetic NPs and quantum dots are promising model systems for the design of bioanalytical sensors and biological enzyme assemblies. In this overview, we aimed to improve the current knowledge of interactions between dehydrogenase enzymes and NPs and to introduce dehydrogenases with industrial and medical applications. Also, bioconjugation of NPs with dehydrogenase enzymes has broad applications in biocatalysis and nanomedicine in the field of drug discovery. However, studies on the characterization of NP-enzyme complexes show that the anatomy and activity of enzymes are dependent on the chemistry of NP ligands, NP size, and labeling methods. Moreover, the NPprotein conjugates show increased/decreased enzymatic activities, depending on the NP features.
Conclusion: In this study, we reviewed the findings related to NP-enzyme interactions for nanotechnology applications and conjugation techniques. We also highlighted several challenges associated with the NP-enzyme interactions, including the stability and reusability of enzymes in NP-enzyme formation.
Export Options
About this article
Cite this article as:
Porzani J. Samaneh , Lorenzi S. Adriana, Eghtedari Masoumeh and Nowruzi Bahareh *, Interaction of Dehydrogenase Enzymes with Nanoparticles in Industrial and Medical Applications, and the Associated Challenges: A Mini-review, Mini-Reviews in Medicinal Chemistry 2021; 21 (11) . https://dx.doi.org/10.2174/1570193X17666201119152944
DOI https://dx.doi.org/10.2174/1570193X17666201119152944 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Drugs and Mitochondria
Mitochondria play a central role in the life and death of cells. They are not merely the center for energy metabolism but are also the headquarters for different catabolic and anabolic processes, calcium fluxes, and various signaling pathways. Mitochondria maintain homeostasis in the cell by interacting with reactive oxygen-nitrogen species ...read more
Mitochondria as a Therapeutic Target in Metabolic Disorders
Mitochondria are the primary site of adenosine triphosphate (ATP) production in mammalian cells. Moreover, these organelles are an important source of reactive oxygen and nitrogen species in virtually any nucleated cell type. The modulation of a myriad of cellular signaling pathways depends on the mitochondrial physiology. Mitochondrial dysfunction is observed ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Stability, Disposition, and Penetration of Catalytic Antioxidants Mn-Porphyrin and Mn-Salen and of Methylprednisolone in Spinal Cord Injury
Central Nervous System Agents in Medicinal Chemistry “SLY AS A FOXO”: New Paths with Forkhead Signaling in the Brain
Current Neurovascular Research Recent Advances in Image-Based Stem-Cell Labeling and Tracking, and Scaffold-Based Organ Development in Cardiovascular Disease
Recent Patents on Medical Imaging NGS Technologies as a Turning Point in Rare Disease Research , Diagnosis and Treatment
Current Medicinal Chemistry Consequences of Iron Accumulation in Microglia and its Implications in Neuropathological Conditions
CNS & Neurological Disorders - Drug Targets Extranuclear Localization of SIRT1 and PGC-1α: An Insight into Possible Roles in Diseases Associated with Mitochondrial Dysfunction
Current Molecular Medicine The NMDA Receptor as a Therapeutic Target in Major Depressive Disorder
CNS & Neurological Disorders - Drug Targets Effects of Synthetic Peptides on the Inflammatory Response and their Therapeutic Potential
Mini-Reviews in Medicinal Chemistry Oxidative Stress and Cancer
Current Pharmaceutical Design Mitochondrial Biogenesis: A Therapeutic Target for Neurodevelopmental Disorders and Neurodegenerative Diseases
Current Pharmaceutical Design Clinical Characteristics and Possible Drug Targets in Autosomal Dominant Spinocerebellar Ataxias
CNS & Neurological Disorders - Drug Targets RAGE: A Multi-Ligand Receptor Unveiling Novel Insights in Health and Disease
Current Medicinal Chemistry Stem Cells: An Overview of the Current Status of Therapies for Central and Peripheral Nervous System Diseases
Current Medicinal Chemistry Targeting TRPs in Neurodegenerative Disorders
Current Topics in Medicinal Chemistry Potential Drugs Targeting Microglia: Current Knowledge and Future Prospects
CNS & Neurological Disorders - Drug Targets Editorial (Thematic Issue: Current Update on Association Between Alzheimer’s Disease and Type 2 Diabetes: Volume I)
CNS & Neurological Disorders - Drug Targets Understanding Abnormal c-JNK/p38MAPK Signaling in Amyotrophic Lateral Sclerosis: Potential Drug Targets and Influences on Neurological Disorders
CNS & Neurological Disorders - Drug Targets Amyloid β Accumulation Assessed with <sup>11</sup>C-Pittsburgh Compound B PET and Postmortem Neuropathology
Current Alzheimer Research Epigenetic and Disease Targets by Polyphenols
Current Pharmaceutical Design Using Small Molecule GSK3β Inhibitors to Treat Inflammation
Current Medicinal Chemistry